ArticleMedicine2019

Efficacy of anti-PD-1 antibody SHR-1210 as second-line treatment in hepatocellular carcinoma patient with sorafenib resistance: A case report.

Hong Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.